The incoming management apparently developed the Glucose Blood...

The incoming management apparently developed the Glucose Blood kit for Diabetics - so people can test themselves at home to monitor there blood sugar levels and Roche made millions out of it, They are also the same people that took the mecury thermometer used only in Doctors Surgery in the past and transformed it into the electronic Thermometer that can be used by everyday families at home. Now they are running Epat Technologies, which is the front runner for the CSIRO 2016 award and I noticed ResApp hasn't even been nominated. Can you see where this is all going? Given trials have been on going thru the University Commercialisation could be close and therefore from a trading point of view if it's only around the corner why would anyone sell till then and miss out on that upside - I don't expect to much stock to come out initially and therefore in the back of everyone's mind will be the 10 cent mark and when traders who act like predators smell money I expect them to come in real hard once they identify that this could go - so my thoughts are this is earmarked for 10 initially